Summary The dapsone/creatinine ratios of urine samples collected from out-patients attending a mission hospital clinic in North-east India indicated that only about a half of the patients had ingested their prescribed dapsone within the previous 24 h.
Previous investigations undertaken in various parts of Africa and Asia have shown that leprosy patients often self-administer their prescribed dapsone treatment irregularly.l-s This report describ es a study of dapsone complian ce among patients being treated by the Leprosy Mission Hospital , Muzaffarpur, in North-east India.
Methods
Urine samples were collected from male staff members of the hospital who were not taking dapsone, from male in-patients 24-h after their previous daily supervised dose of 100 mg dapsone and fro m male out-patients at the time of their visit to collect a further stock of 100 mg dapsone tablets fo r daily self administration. A small crystal of thymol was then added to each urine sample and the samples stored without refrigeration at ambient temperatures of 75° to 100°F for 4 months until analysis in London. Urinary concentrations of diazotisable compounds (as dapsone equivalents) were det ermined by a modification of the Bratton and Marshall procedure , creatinine concentrations were determined using the alkaline picrate method, and 'dapsone/creatinine' ratios then calculated. 6
In about a fifth of the samples (14 out of 72) abnormally low concentrations of creatinine (less than 0.1 mg/ml) were encountered despite seemingly normal levels of diazotisable compounds. It was surmized that in these samples creatinine must have been bacterially degraded, although the reason why the thymol had apparently fa iled to act as a pre servative is not understood. The creatinine concentrations of the remaining 58 samples appeared to be normal (range 0. 16 to 1.84 mg/ml, mean 0.53 mg/ml). Although the numbers of control samples were small, the results obtained were in accord with those obtained in previous studies fr om Addis Ababa in Ethiopia! and fr om Dichpalli in India.7 Thus the mean dapsone/creatinine ratios (p.. g/mg) averaged 9 for the 5 controls not on dapsone as compared with 7 fr om Addis Ababa and Dichpalli, while those from the supervised controls being treated with 100 mg dapsone a day averaged 92 as compared with 80 fr om Addis Ababa and 102 fr om Dichpalli.
The results obtained fr om the 44 satisfactory urine samples collected from the out-patients were interpreted in the light of those from the treated and untreated controls in Muzaffa rp ur, Dichpalli and Addis Ababa. Dapsone/ creatinine ratios of greater than 50, indicating that a dose of 100 mg dapsone had been taken within the 24 h prior to the clinic, were fo und in only about a half of the urine samples. Furthermore 11 of the urine samples had dapsone/ creatinine ratios of less than 16.8 , the highest value for the untreated controls, indicating that about a quarter of the patients had probab ly not taken their prescribed treatment for at least the previo us 3-4 days. The results of this small study therefore support the findings of previous investigations indicating that poor dapsone compliance is probably very widespre ad . It was also apparent that some patients failed to appreciate that their running out of dapsone tablets was often a consequence of missed out-patient clinic appoint ments. Hence the importance of educating patients about the dangers of irregular treatment.
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